Logo image
Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients
Journal article   Open access   Peer reviewed

Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients

R. Li, X. Sun, Y. Shu, Yuge Wang, Li Xiao, Z. Wang, X. Hu, A.G. Kermode and W. Qiu
Journal of Neuroimmunology, Vol.313, pp.56-60
2017
pdf
SERUMCCL20.pdfDownloadView
Author’s Version Open Access
url
Link to Published Version *Subscription may be requiredView

Abstract

CCL20 is a potentially important component in the pathogenesis of multiple sclerosis (MS). SIRT1 exhibits a negative regulatory effect on a variety of inflammatory cytokines and can relieve experimental autoimmune encephalomyelitis. The association between the level of CCL20 and SIRT1 activity in MS patients has not been investigated. In the present study, blood samples were collected from 38 RRMS patients and 40 healthy controls. The serum CCL20 levels were measured by ELISA. SIRT1 activity was evaluated by fluorometric assay. We revealed elevated serum CCL20 concentrations in MS, and discovered an inverse correlation between CCL20 and SIRT1 activity in MS patients.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

170 File views/ downloads
47 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.264 Longevity
1.264.1102 Resveratrol & Sirtuins
Web Of Science research areas
Immunology
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image